Stimulation of the semicircular canals can artificially control human walking and balance
By applying electrical currents across the heads of people while they walk, researchers have improved our understanding of how our vestibular system helps us maintain upright posture; at the same time, the researchers found that the stimulus could be applied in a way that allowed a person who was walking straight ahead to be steered by "remote control" without her balance being affected. The find...Bacteria could make new library of cancer drugs that are too complex to create artificially
Researchers at the University of Warwick are examining a way of using bacteria to manufacture a new suite of potential anti-cancer drugs that are difficult to create synthetically on a lab bench. This group of antibiotics has stimulated much recent interest as they can be used to target and k...Hair-growth drug artificially lowers PSA levels in prostate cancer screening, study finds
The popular hair-growth drug finasteride, taken by millions of balding men, artificially lowers the results of the prostate-specific antigen (PSA) test, the standard screening test for prostate cancer, a multicenter study has found. The study, involving 308 men ranging in age from 40 to 60 years old, is available online in the British medical journal The Lancet and is scheduled to be publ...Artificially made protein to inhibit angiogenesis
Researchers of Medical College of Georgia had successfully made a protein// that will stop the process of angiogenesis. Angiogenesis is the abnormal growth of blood vessels that may lead to obstructed vision or growth of a tumor. The new protein, when applied to animals suffering from corneal injury or skin cancer called melanoma, reduced the blood vessel proliferation by...Hair-Growth Drug Artificially Lowers Psa Levels in Prostate Cancer Screening
The popular hair-growth drug finasteride, taken by millions of balding men, artificially lowers the results of the prostate-specific antigen (PSA) test,// the standard screening test for prostate cancer, a multicenter study has found. The study, involving 308 men ranging in age from 40 to 60 years old, is available online in the British medical journal The Lancet and is scheduled to be...